Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 795 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Highlights the Importance of a Strong EU Commitment Towards Robust Science and Innovation Policies Following Meeting of EU Research Ministers on 29 May... Metastatic Breast Cancer: ESMO Clinical Practice Guideline EMA Recommends Extending Indications for Decitabine / Cedazuridine MOST POPULAR Thanks For Making This GivingTuesday Our Best One Yet! December 1, 2021 Experts Urge to Remove Care Inequalities for Adolescents and Young Adults... April 8, 2021 Coping With Life After a Bone Marrow Transplant: A Survivor’s Story August 15, 2023 ESMO Targeted Anticancer Therapies Congress 2021, 1-2 March February 23, 2021 Load more HOT NEWS Improving research with registered reports Hospital Mistakenly Gave Woman a Mastectomy, Then Postponed Her Reconstruction for... COVID-19, Cancer, and Uncertainty: An Oncologist’s Perspective on Coping FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection
